rs202059967
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_006440.5(TXNRD2):āc.1341T>Gā(p.Tyr447Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,613,726 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006440.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNRD2 | NM_006440.5 | c.1341T>G | p.Tyr447Ter | stop_gained | 15/18 | ENST00000400521.7 | NP_006431.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNRD2 | ENST00000400521.7 | c.1341T>G | p.Tyr447Ter | stop_gained | 15/18 | 1 | NM_006440.5 | ENSP00000383365 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152116Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000565 AC: 141AN: 249568Hom.: 0 AF XY: 0.000746 AC XY: 101AN XY: 135404
GnomAD4 exome AF: 0.000293 AC: 428AN: 1461492Hom.: 2 Cov.: 32 AF XY: 0.000384 AC XY: 279AN XY: 727050
GnomAD4 genome AF: 0.000217 AC: 33AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74438
ClinVar
Submissions by phenotype
Glucocorticoid deficiency 5 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Oct 15, 2018 | This variant is interpreted as Likely Pathogenic, for Glucocorticoid deficiency 5, autosomal recessive. The following ACMG Tag(s) were applied: PP1 => Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (https://www.ncbi.nlm.nih.gov/pubmed/24601690). PVS1-Moderate => Stop-gain mutation predicted to be loss of function. TXNRD2 is a selenoprotein and the selenocysteine residue is essential for enzymatic activity. The mutation is predicted to cause protein truncation prior the selenocysteine residue (http://www.uniprot.org/uniprot/Q9NNW7). PS3 => Well-established functional studies show a deleterious effect (https://www.ncbi.nlm.nih.gov/pubmed/24601690). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 22, 2017 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; This variant is associated with the following publications: (PMID: 26300845, 31712860, 34297361, 34426522, 38011841, EdavanaS2023[Abstract], 36674647, 24601690) - |
Primary dilated cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at